Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of LASS4 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ti |
More info about LASS4 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB10111 |
| Product name: | LASS4 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of LASS4. |
| Gene id: | 79603 |
| Gene name: | LASS4 |
| Gene alias: | CerS4|FLJ12089|Trh1 |
| Gene description: | LAG1 homolog, ceramide synthase 4 |
| Immunogen: | A synthetic peptide of human LASS4. |
| Form: | Liquid |
| Recommend dilutions: | Western blot (1 mg/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.08% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis using LASS4 polyclonal antibody (Cat # PAB10111) at 0.75 ug/mL on human lung lysate 14 ug/lane. Lane 1, antibody plus 27 ug blocking peptide. Lane 2, antibody alone. |
| Applications: | WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1.Min J, Mesika A, Sivaguru M, Van Veldhoven PP, Alexander H, Futerman AH, Alexander S. Mol Cancer Res. 2007 Aug;5(8):801-12. |